Research Platforms & Clinical Cohorts

Represent the basis on which a large proportion of scientific research funded through competitive grants is conducted. They provide an important competitive advantage when submitting research grants, the opportunity to carry out preliminary, exploratory work and to host PhD and career development students. MRCG researchers have equal access to all platforms and cohorts.

Health Demographic and Surveillance Systems

Supports demographic research, e.g. adult mortality; facilitates identification of clinical cases/study subjects for all research themes; and provide a well-defined denominator for estimating morbidity/mortality rates. It provides an excellent opportunity to investigate important but neglected causes of morbidity and mortality.

West Africa Collaboration

Active since building strong collaborative links with other West African institutions and has actively organised capacity building activities consisting of short course, post-graduate training and institutional strengthening, e.g. Regional HIV database system, item-tracking biobank system and development of a clinical trial unit at the Laboratories Bacteriologie et Virologie (LBV), Universite Cheikh Anta Diop (UCAD) in Dakar, partly supported also by competitive funding.

Clinical Research

Combines MRCG clinical services, the Sukuta Health Centre often used by the Vaccines & Immunity Theme to carry out clinical trials on vaccines, and the paediatric ward of the Edward Francis Small Teaching Hospital in Banjul. Merging these three different entities has the objective of better coordination for increasing clinical research.

Tuberculosis Case Contact

Has existed since 2001 and provides the ideal framework to identify correlates of protection and of risk in populations who are TB-exposed, infected or diseased. It hosts studies of household transmission dynamics, biomarker research for diagnosis and treatment responses, and facilitates evaluation of novel diagnostic tests and of genetic and immunologic host markers, all of which are required to inform the TB vaccine designs of the future.